Dr. Ivan Casselman says he has been setting himself up to work in the psychedelic industry for quite some time.
Canadian company NeuroPharm Inc. files application with the U.S. Patent and Trademark Office in connection with a psychedelic therapy.
Father John Misty doesn’t make psychedelic music per se. What it may lack in acid-rock trappings, it makes up for with insights the artist attributes to his drug trips
Australian researchers review the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder
The centre’s cofounders include UC Berkeley neuroscientist David Presti, psychologist Dacher Keltner, and journalism professor Michael Pollan
The controlled clinical experiment constitutes the first study in a long time to revisit the potential of LSD as an analgesic
Therapeutic breakthroughs suggest that the historical reputation of psychedelics as dangerous has unfairly overshadowed a more optimistic interpretation
Health Canada allows certain companies to conduct research on drugs
Four patients battling cancer seek psilocybin-assisted psychotherapy